The global market for Human Somatotropin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Human Somatotropin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Somatotropin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Human Somatotropin in Growth Hormone Deficiency (GHD) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human Somatotropin include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Somatotropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Somatotropin.

The Human Somatotropin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Somatotropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Somatotropin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Somatotropin Market Report

Report Metric	Details
Report Name	Human Somatotropin Market
Segment by Type	Powder Solvent
Segment by Application	Growth Hormone Deficiency (GHD) Turner Syndrome Chronic Renal Insufficiency Prader Willi Syndrome Small for Gestational Age SHOX Deficiency Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Somatotropin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Somatotropin Market report?

Ans: The main players in the Human Somatotropin Market are Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology

What are the Application segmentation covered in the Human Somatotropin Market report?

Ans: The Applications covered in the Human Somatotropin Market report are Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others

What are the Type segmentation covered in the Human Somatotropin Market report?

Ans: The Types covered in the Human Somatotropin Market report are Powder, Solvent

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Somatotropin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Powder

1.2.3 Solvent

1.3 Market by Application

1.3.1 Global Human Somatotropin Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Growth Hormone Deficiency (GHD)

1.3.3 Turner Syndrome

1.3.4 Chronic Renal Insufficiency

1.3.5 Prader Willi Syndrome

1.3.6 Small for Gestational Age

1.3.7 SHOX Deficiency

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Somatotropin Market Perspective (2020-2031)

2.2 Global Human Somatotropin Growth Trends by Region

2.2.1 Global Human Somatotropin Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Somatotropin Historic Market Size by Region (2020-2025)

2.2.3 Human Somatotropin Forecasted Market Size by Region (2026-2031)

2.3 Human Somatotropin Market Dynamics

2.3.1 Human Somatotropin Industry Trends

2.3.2 Human Somatotropin Market Drivers

2.3.3 Human Somatotropin Market Challenges

2.3.4 Human Somatotropin Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Somatotropin Players by Revenue

3.1.1 Global Top Human Somatotropin Players by Revenue (2020-2025)

3.1.2 Global Human Somatotropin Revenue Market Share by Players (2020-2025)

3.2 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Somatotropin Revenue

3.4 Global Human Somatotropin Market Concentration Ratio

3.4.1 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2024

3.5 Global Key Players of Human Somatotropin Head office and Area Served

3.6 Global Key Players of Human Somatotropin, Product and Application

3.7 Global Key Players of Human Somatotropin, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Somatotropin Breakdown Data by Type

4.1 Global Human Somatotropin Historic Market Size by Type (2020-2025)

4.2 Global Human Somatotropin Forecasted Market Size by Type (2026-2031)

5 Human Somatotropin Breakdown Data by Application

5.1 Global Human Somatotropin Historic Market Size by Application (2020-2025)

5.2 Global Human Somatotropin Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Somatotropin Market Size (2020-2031)

6.2 North America Human Somatotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Somatotropin Market Size by Country (2020-2025)

6.4 North America Human Somatotropin Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Somatotropin Market Size (2020-2031)

7.2 Europe Human Somatotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Somatotropin Market Size by Country (2020-2025)

7.4 Europe Human Somatotropin Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Somatotropin Market Size (2020-2031)

8.2 Asia-Pacific Human Somatotropin Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Somatotropin Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Somatotropin Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Somatotropin Market Size (2020-2031)

9.2 Latin America Human Somatotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Somatotropin Market Size by Country (2020-2025)

9.4 Latin America Human Somatotropin Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Somatotropin Market Size (2020-2031)

10.2 Middle East & Africa Human Somatotropin Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Somatotropin Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Somatotropin Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Details

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Human Somatotropin Introduction

11.1.4 Novo Nordisk Revenue in Human Somatotropin Business (2020-2025)

11.1.5 Novo Nordisk Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Human Somatotropin Introduction

11.2.4 Pfizer Revenue in Human Somatotropin Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Human Somatotropin Introduction

11.3.4 Eli Lilly Revenue in Human Somatotropin Business (2020-2025)

11.3.5 Eli Lilly Recent Development

11.4 Merck Serono

11.4.1 Merck Serono Company Details

11.4.2 Merck Serono Business Overview

11.4.3 Merck Serono Human Somatotropin Introduction

11.4.4 Merck Serono Revenue in Human Somatotropin Business (2020-2025)

11.4.5 Merck Serono Recent Development

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Details

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Human Somatotropin Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Human Somatotropin Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Recent Development

11.6 Ferring Pharmaceuticals

11.6.1 Ferring Pharmaceuticals Company Details

11.6.2 Ferring Pharmaceuticals Business Overview

11.6.3 Ferring Pharmaceuticals Human Somatotropin Introduction

11.6.4 Ferring Pharmaceuticals Revenue in Human Somatotropin Business (2020-2025)

11.6.5 Ferring Pharmaceuticals Recent Development

11.7 GeneScience Pharmaceuticals

11.7.1 GeneScience Pharmaceuticals Company Details

11.7.2 GeneScience Pharmaceuticals Business Overview

11.7.3 GeneScience Pharmaceuticals Human Somatotropin Introduction

11.7.4 GeneScience Pharmaceuticals Revenue in Human Somatotropin Business (2020-2025)

11.7.5 GeneScience Pharmaceuticals Recent Development

11.8 Ipsen

11.8.1 Ipsen Company Details

11.8.2 Ipsen Business Overview

11.8.3 Ipsen Human Somatotropin Introduction

11.8.4 Ipsen Revenue in Human Somatotropin Business (2020-2025)

11.8.5 Ipsen Recent Development

11.9 LG Life Sciences

11.9.1 LG Life Sciences Company Details

11.9.2 LG Life Sciences Business Overview

11.9.3 LG Life Sciences Human Somatotropin Introduction

11.9.4 LG Life Sciences Revenue in Human Somatotropin Business (2020-2025)

11.9.5 LG Life Sciences Recent Development

11.10 Sandoz International

11.10.1 Sandoz International Company Details

11.10.2 Sandoz International Business Overview

11.10.3 Sandoz International Human Somatotropin Introduction

11.10.4 Sandoz International Revenue in Human Somatotropin Business (2020-2025)

11.10.5 Sandoz International Recent Development

11.11 Anhui Anke Biotechnology

11.11.1 Anhui Anke Biotechnology Company Details

11.11.2 Anhui Anke Biotechnology Business Overview

11.11.3 Anhui Anke Biotechnology Human Somatotropin Introduction

11.11.4 Anhui Anke Biotechnology Revenue in Human Somatotropin Business (2020-2025)

11.11.5 Anhui Anke Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ferring Pharmaceuticals

GeneScience Pharmaceuticals

Ipsen S A

LG Life Sciences

Sandoz International

Anhui Anke Biotechnology

List of Tables

Table 1. Global Human Somatotropin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Powder

Table 3. Key Players of Solvent

Table 4. Global Human Somatotropin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Human Somatotropin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Human Somatotropin Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Human Somatotropin Market Share by Region (2020-2025)

Table 8. Global Human Somatotropin Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Human Somatotropin Market Share by Region (2026-2031)

Table 10. Human Somatotropin Market Trends

Table 11. Human Somatotropin Market Drivers

Table 12. Human Somatotropin Market Challenges

Table 13. Human Somatotropin Market Restraints

Table 14. Global Human Somatotropin Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Human Somatotropin Market Share by Players (2020-2025)

Table 16. Global Top Human Somatotropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Somatotropin as of 2024)

Table 17. Ranking of Global Top Human Somatotropin Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Human Somatotropin Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Human Somatotropin, Headquarters and Area Served

Table 20. Global Key Players of Human Somatotropin, Product and Application

Table 21. Global Key Players of Human Somatotropin, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Human Somatotropin Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Human Somatotropin Revenue Market Share by Type (2020-2025)

Table 25. Global Human Somatotropin Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Human Somatotropin Revenue Market Share by Type (2026-2031)

Table 27. Global Human Somatotropin Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Human Somatotropin Revenue Market Share by Application (2020-2025)

Table 29. Global Human Somatotropin Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Human Somatotropin Revenue Market Share by Application (2026-2031)

Table 31. North America Human Somatotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Human Somatotropin Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Human Somatotropin Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Human Somatotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Human Somatotropin Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Human Somatotropin Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Human Somatotropin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Human Somatotropin Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Human Somatotropin Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Somatotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Human Somatotropin Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Human Somatotropin Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Human Somatotropin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Human Somatotropin Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Human Somatotropin Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novo Nordisk Company Details

Table 47. Novo Nordisk Business Overview

Table 48. Novo Nordisk Human Somatotropin Product

Table 49. Novo Nordisk Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 50. Novo Nordisk Recent Development

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Human Somatotropin Product

Table 54. Pfizer Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Eli Lilly Company Details

Table 57. Eli Lilly Business Overview

Table 58. Eli Lilly Human Somatotropin Product

Table 59. Eli Lilly Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 60. Eli Lilly Recent Development

Table 61. Merck Serono Company Details

Table 62. Merck Serono Business Overview

Table 63. Merck Serono Human Somatotropin Product

Table 64. Merck Serono Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 65. Merck Serono Recent Development

Table 66. F. Hoffmann-La Roche Company Details

Table 67. F. Hoffmann-La Roche Business Overview

Table 68. F. Hoffmann-La Roche Human Somatotropin Product

Table 69. F. Hoffmann-La Roche Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 70. F. Hoffmann-La Roche Recent Development

Table 71. Ferring Pharmaceuticals Company Details

Table 72. Ferring Pharmaceuticals Business Overview

Table 73. Ferring Pharmaceuticals Human Somatotropin Product

Table 74. Ferring Pharmaceuticals Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 75. Ferring Pharmaceuticals Recent Development

Table 76. GeneScience Pharmaceuticals Company Details

Table 77. GeneScience Pharmaceuticals Business Overview

Table 78. GeneScience Pharmaceuticals Human Somatotropin Product

Table 79. GeneScience Pharmaceuticals Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 80. GeneScience Pharmaceuticals Recent Development

Table 81. Ipsen Company Details

Table 82. Ipsen Business Overview

Table 83. Ipsen Human Somatotropin Product

Table 84. Ipsen Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 85. Ipsen Recent Development

Table 86. LG Life Sciences Company Details

Table 87. LG Life Sciences Business Overview

Table 88. LG Life Sciences Human Somatotropin Product

Table 89. LG Life Sciences Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 90. LG Life Sciences Recent Development

Table 91. Sandoz International Company Details

Table 92. Sandoz International Business Overview

Table 93. Sandoz International Human Somatotropin Product

Table 94. Sandoz International Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 95. Sandoz International Recent Development

Table 96. Anhui Anke Biotechnology Company Details

Table 97. Anhui Anke Biotechnology Business Overview

Table 98. Anhui Anke Biotechnology Human Somatotropin Product

Table 99. Anhui Anke Biotechnology Revenue in Human Somatotropin Business (2020-2025) & (US$ Million)

Table 100. Anhui Anke Biotechnology Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Human Somatotropin Picture

Figure 2. Global Human Somatotropin Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Somatotropin Market Share by Type: 2024 VS 2031

Figure 4. Powder Features

Figure 5. Solvent Features

Figure 6. Global Human Somatotropin Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Somatotropin Market Share by Application: 2024 VS 2031

Figure 8. Growth Hormone Deficiency (GHD) Case Studies

Figure 9. Turner Syndrome Case Studies

Figure 10. Chronic Renal Insufficiency Case Studies

Figure 11. Prader Willi Syndrome Case Studies

Figure 12. Small for Gestational Age Case Studies

Figure 13. SHOX Deficiency Case Studies

Figure 14. Others Case Studies

Figure 15. Human Somatotropin Report Years Considered

Figure 16. Global Human Somatotropin Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Human Somatotropin Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Human Somatotropin Market Share by Region: 2024 VS 2031

Figure 19. Global Human Somatotropin Market Share by Players in 2024

Figure 20. Global Top Human Somatotropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Somatotropin as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Human Somatotropin Revenue in 2024

Figure 22. North America Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Human Somatotropin Market Share by Country (2020-2031)

Figure 24. United States Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Human Somatotropin Market Share by Country (2020-2031)

Figure 28. Germany Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Human Somatotropin Market Share by Region (2020-2031)

Figure 36. China Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Human Somatotropin Market Share by Country (2020-2031)

Figure 44. Mexico Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Human Somatotropin Market Share by Country (2020-2031)

Figure 48. Turkey Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Human Somatotropin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Novo Nordisk Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 54. Merck Serono Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 56. Ferring Pharmaceuticals Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 57. GeneScience Pharmaceuticals Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 58. Ipsen Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 59. LG Life Sciences Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 60. Sandoz International Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 61. Anhui Anke Biotechnology Revenue Growth Rate in Human Somatotropin Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions